Skip to content
777 Sourcing.

Capability

AAV-based RNA interference (RNAi)

Suppliers
1
States & provinces
1
Countries
1

1 aav-based rna interference (rnai) supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

CAVGENE THERAPEUTICS, INC.

EAST LANSING, MI

CavGene Therapeutics, Inc. is a pre-clinical stage gene therapy company founded in November 2022 and headquartered in East Lansing, Michigan. It is developing proprietary AAV-based RNA interference (RNAi) therapeutics targeting specific L-type calcium channel isoforms in the brain for the treatment of neurodegenerative disease, including levodopa-induced dyskinesias in Parkinson's disease.

gene therapypre-clinical research

Compiled from public sources

Related capabilities

Other processes offered by the shops that list AAV-based RNA interference (RNAi).

Browse all capabilities